Zimmer Biomet Holdings Inc (NYSE:ZBH)
$ 121.31 -0.13 (-0.11%) Market Cap: 24.96 Bil Enterprise Value: 30.52 Bil PE Ratio: 26.26 PB Ratio: 1.98 GF Score: 83/100

Zimmer Biomet Holdings Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 04:15PM GMT
Release Date Price: $121.87 (-0.08%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Great. Thanks, everyone. We can get started here. If you want to take a seat. My name is Robbie Marcus. I'm the Medtech analyst at JPMorgan. Really happy to introduce our next session. I'm going to bring up Ivan Tornos, the CEO of Zimmer Biomet for a presentation, then we'll do some Q&A afterwards.

Ivan?

Ivan Tornos
Zimmer Biomet Holdings, Inc. - COO, President, CEO & Director

All right. Good morning. I was expecting some music, some ACDC and (inaudible), but I guess I'm not getting that today. Yes, thank you, Robbie. My name is Ivan Tornos. I'm the President and CEO of Zimmer Biomet. I've been with the company, 5 years. I've been in this job, 111 days and 2 hours. So I look forward to some questions later on.

But before we get started, I do want to thank you, Robbie, for hosting this decision. I want to thank, obviously, everybody for being here this morning. I want to thank my team. We got about 10 people here from Zimmer Biomet. I want to thank all of you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot